Absci Corporation (ABSI) vs Ocular Therapeutix, Inc. (OCUL)
- Absci Corporation ABSI 7.58 +1.34%
- Ocular Therapeutix, Inc. OCUL 6.01 0.00%
Absci Corporation and Ocular Therapeutix, Inc. are both Biotechnology companies. Absci Corporation and Ocular Therapeutix, Inc. are of similar size ($1.3B and $1.3B). Ocular Therapeutix, Inc. grew revenue faster over the last twelve months: −9.68% against −47.2%. Ocular Therapeutix, Inc. has the higher net margin (−648.6% vs −8,451.3%) and the higher return on invested capital (0.00% vs −182.0%). Across the 18 metrics below, Absci Corporation leads on 9 and Ocular Therapeutix, Inc. on 9.
Valuation
Profitability
| Metric | ABSI | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.32% | 70.18% |
| Operating margin | (8,812.31%) | (680.91%) | 0.00% |
| Net margin | (8,451.31%) | (648.64%) | 0.00% |
| Free cash flow margin | (7,550.91%) | (530.00%) | 0.00% |
| Return on equity | (58.59%) | (93.48%) | (50.72%) |
| Return on assets | (51.87%) | (64.30%) | (45.56%) |
| Return on invested capital | (181.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack